Cobepa S.A.’s Acquisition of BioAgilytix


Wells Fargo Securities, LLC is acting as lead financial advisor to BioAgilytix. Lincoln International, LLC is also serving as a financial advisor to the company. Choate Hall & Stewart LLP is serving as legal counsel to BioAgilytix.

BioAgilytix, a leading provider of large molecule bioanalytical testing services, executed an agreement to be acquired by Cobepa S.A., a privately-held investment company.

Riverside Partners, a Boston-based private equity firm, originally acquired BioAgilytix in 2013 and has built the company into a recognized global leader in large molecule bioanalysis. The acquisition by Cobepa will provide BioAgilytix with increased funding and resources to meet growing demand for its high-quality services, driven by its strong scientific reputation and leading expertise in biologics development.

Choate advised with a team including T.J. Murphy (Picture), Mark A. Bellis, Reginald St. Louis, Louis J. Marett, Kevin M. Sarro, Wells W. Miller, Benjamin Gibbons and Robert M. Buchanan, Jr..

Involved fees earner: T.J. Murphy – Choate; Mark Bellis – Choate; Reginald St. Louis – Choate; Louis Marett – Choate; Kevin Sarro – Choate; Wells Miller – Choate; Benjamin Gibbons – Choate; Robert Buchanan – Choate;

Law Firms: Choate;

Clients: BioAgilytix Labs, LLC;

Author: Ambrogio Visconti